Clinical Trial Update: Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis [Phase 4]

View source ↗

Summary

A Phase 4 trial completed evaluating albumin for acute hepatic encephalopathy in patients with cirrhosis, reporting on its efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• Albumin

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Hepatic Encephalopathy | Phase 4 | Status: COMPLETED